Sopharma (Bulgaria)

Recent papers from Sopharma (Bulgaria)

1. Early Health Technology Assessment (HTA) of Olpasiran and Pelacarsen for Secondary Prevention of Coronary Heart Disease (CHD)ClinicoEconomics and Outcomes Research · 2026
2. Serological Study of Bulgarian Patients With BrucellosisPROBLEMS of Infectious and Parasitic Diseases · 2021
3. Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide – which is the better alternative? A meta-analysisSystematic Reviews · 2020
4. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2Biomedicine & Pharmacotherapy · 2020
5. Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptinsDiabetology & Metabolic Syndrome · 2015
6. Competitive dynamics in pharmaceutical markets: A case study in the chronic cardiac disease marketJournal of the Operational Research Society · 2013